Trials / Unknown
UnknownNCT01055743
The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma
A Randomized, Controlled Trial of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Simcere Pharmaceutical Co., Ltd · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the clinical efficacy and safety of fluorouracil implants regional chemotherapy during the surgical treatment for early-stage hepatocellular carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Radical resection | Radical resection of hepatocellular carcinoma |
| DRUG | Fluorouracil Implants | Implanted during the surgical treatment |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2010-01-26
- Last updated
- 2010-01-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01055743. Inclusion in this directory is not an endorsement.